Our previous research demonstrated that TRPA1 plays a significant role in the FGFR2c-mediated enhancement of EMT and invasion in the context of pancreatic adenocarcinoma [23]. This evidence concerns the gene TRPA1 and pancreatic adenocarcinoma.